E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks

摘要: Abstract Context Use of electronic cigarettes (ECs) is on the rise in most high-income countries. Smoking conventional a known risk factor for urologic malignancy incidence, progression, and mortality, as well other health indicators. The potential impact EC use therefore clinical interest to urology community. Objective To review available data current use, including benefits patients, issues linked toxicology constituents, how this might translate into risks. Evidence acquisition A Medline search was carried out August 2016 studies reporting outcomes use. Snowballing techniques were also used identify relevant from recent systematic reviews. narrative synthesis around outcomes, toxicology, smoking cessation policy out. We found no date that have been specifically designed prospectively assess risks, even an observational setting. Generating such would be important contribution debate role ECs public practice. There evidence Cochrane RCTs can support cessation. are emerging indicating potentially harmful components tobacco-specific nitrosamines, polyaromatic hydrocarbons, heavy metals could possible Conclusions useful tool encourage cigarette smoking. However, collection specific needed clarify patient benefits, adverse events. Patient summary While help some people stop smoking, their overall not clear.